Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Xu Wang, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Originally developed for type 2 diabetes management (as Ozempic), it earned FDA approval specifically for weight loss under the brand name Wegovy in 2021
As of December 2024, the FDA approved tirzepatide for treatment of moderate-to-severe obstructive sleep apnea (OSA) in patients with obesity based on the results of two trials
This is especially important if you're taking prescription medications, managing metabolic conditions, or currently using prescription GLP-1 medications
US$ 29.57
US$ 26.23
US$ 25.41
US$ 28.89
US$ 21.96
US$ 23.58
